CVS Health Analysts Recommendations and Consensus

CVS -- USA Stock  

USD 63.37  2.15  0.03%

The current analyst and expert consensus on CVS Health is Buy with 7 hold recommendations. The current projected target price consensus is 89.5 with 18 analysts opinions. One of the most common ways CVS Health analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to CVS Health vendors, executives, and/or customers. CVS Health recommendation module provides expert sentiment on the projected CVS Health target price to derive its highest and lowest estimates based on target price standard deviation of 9.089. Check also Macroaxis Advice on CVS Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

CVS Health Target Price Consensus

Number of Opinions20
Lowered Outlook2
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

CVS Health Target Price Projection

Current Price

CVS Health Market Quote

Low Price63.27Odds
High Price64.091Odds

63.37

Target Price

Analyst Consensus On Target Price

Low Estimate77.0Odds
High Estimate120.0Odds
Number of Analysts18
Standard Deviation9.089

89.5

CVS Health Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Real Goods Solar
Purchased few shares
Traded 2 days ago for 0.52
Pharmaceutical Products
Purchased over 90 shares
Traded 2 days ago for 0.13
Synergy Pharmaceuticals
Purchased few shares
Traded 2 days ago for 0.24
Vital Therapies
Purchased over 500 shares
Traded 2 days ago for 0.26
Pharmaceutical Products
Purchased over 100 shares
Traded 2 days ago for 0.13
Top Penny
Purchased over 100 shares
Traded 2 days ago for 0.8
Check also Macroaxis Advice on CVS Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Search macroaxis.com